-
ABOUT USAffiliated to SSY Group Limited, Hebei Guangxiang Technology Co., Ltd., is a high-tech enterprise specializing in drug research and technology development.
-
INNOVATIONSSY Group Limited has built a relatively perfect scientific research and innovation system with the synergy between “industry, academia, research and application” based on multi-disciplinary integration and multi-directional combination.
-
SUBORDINATEThe group has decided to establish research institutes in its subsidiaries, Hebei Ghuangxiang Drug Research Institute, Jiangsu Best Medical Material Research Institute, and Hebei Hanlin Biological Research Institute.
-
RECRUITWe actively establish a joint talent cultivation mechanism between schools and enterprises, and currently have over 500 high-level talents in various fields such as drug research, analysis, and clinical practice.
-
CONTACTWe will continue to strengthen innovation-driven development, vigorously promote the integration of production and research, constantly improve the five domains: new drugs, biological drugs, traditional Chinese medicine, generic drugs and APIs.
Shijiazhuang No.4 Pharmaceutical has been honored with the title of "Top 50 Private Enterprises Pioneering Independent Innovation."
Category:
Time：2022-01-20
On October 16, the autumnal city of Jinan was pleasantly refreshing and delightful. The "First Tai Shan Pharmaceutical Forum and the 2020 China Pharmaceutical Industry Influence List Release Ceremony," hosted by the Pharmaceutical Industry Chamber of the All-China Federation of Industry and Commerce, was solemnly held here.
On October 16, the autumnal city of Jinan was pleasantly refreshing and delightful. The "First Tai Shan Pharmaceutical Forum and the 2020 China Pharmaceutical Industry Influence List Release Ceremony," hosted by the Pharmaceutical Industry Chamber of the All-China Federation of Industry and Commerce, was solemnly held here.
At the highly anticipated 2020 China Pharmaceutical Industry Influence List Awards Ceremony, Shijiazhuang No.4 Pharmaceutical Co., Ltd. was honored with two prestigious awards: “Top 50 Private Enterprises for Independent Innovation in 2020” and “Top 100 Chinese Pharmaceutical Manufacturers in 2020.” Meanwhile, Su Xuejun, Chairman of Shijiazhuang No.4 Pharmaceutical, was awarded the title of “Top 10 Leaders in China’s Pharmaceutical Industry in 2020.”
It is reported that this forum is themed “Whole Industry, Large Platform, Deep Integration, and Shared Development.” Focusing on the macroeconomic trends, hot topics, and evolving market dynamics facing the pharmaceutical industry, the forum invites entrepreneurs, experts, scholars, and relevant professionals from various fields to engage in discussions and dialogues on current hot topics.
The China Pharmaceutical Industry Influence Ranking event, launched as part of the forum activities, has been successfully held for eight consecutive years and has become an annual flagship event for the industry, attracting widespread attention from the business community.
At the highly anticipated 2020 China Pharmaceutical Industry Influence List Awards Ceremony, Shijiazhuang No.4 Pharmaceutical Co., Ltd. was honored with two prestigious awards: “Top 50 Private Enterprises for Independent Innovation in 2020” and “Top 100 Chinese Pharmaceutical Manufacturers in 2020.” Meanwhile, Su Xuejun, Chairman of Shijiazhuang No.4 Pharmaceutical, was awarded the title of “Top 10 Leaders in China’s Pharmaceutical Industry in 2020.”
It is reported that this forum is themed “Whole Industry, Large Platform, Deep Integration, and Shared Development.” Focusing on the macroeconomic trends, hot topics, and evolving market dynamics facing the pharmaceutical industry, the forum invites entrepreneurs, experts, scholars, and relevant professionals from various fields to engage in discussions and dialogues on current hot topics.
The China Pharmaceutical Industry Influence Ranking event, launched as part of the forum activities, has been successfully held for eight consecutive years and has become an annual flagship event for the industry, attracting widespread attention from the business community.
Keywords:
Recommended News
Share to
SERVICE HOTLINE
Mobile site
E code
Business license